( NASDAQ-NMS:REGN )

News from Sanofi Genzyme A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Nov 17, 2016, 04:00 ET Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease to Begin in the UK

Sanofi Genzyme, the specialty care global business unit of Sanofi, today announced that the first patient in the UK has been enrolled and received...


Nov 03, 2016, 08:20 ET Pivotal Phase 2/3 Trial of Olipudase Alfa for Adult Patients With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease Type B) to Begin in the UK

Sanofi Genzyme, the specialty care global business unit of Sanofi, announced today that the first adult patient in the UK has enrolled and been...


Aug 01, 2016, 02:00 ET Sanofi and Regeneron Announce EMA Acceptance for Review of Marketing Authorisation Application for Sarilumab

Sanofi and Regeneron Pharmaceuticals, Inc. today announced that the European Medicines Agency (EMA) has accepted for review the Marketing...